The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2017

Filed:

Feb. 21, 2016
Applicant:

Hong Kong Baptist University, Hong Kong, HK;

Inventors:

Yinhui Li, Hong Kong, HK;

Di Xu, Hong Kong, HK;

See-Lok Ho, Hong Kong, HK;

Chung-Yan Poon, Hong Kong, HK;

Hei-Nga Chan, Hong Kong, HK;

Hung Wing Li, Hong Kong, HK;

Ricky M. S. Wong, Hong Kong, HK;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 49/10 (2006.01); A61M 5/00 (2006.01); A61K 49/08 (2006.01); C07D 401/06 (2006.01); A61K 47/48 (2006.01); G01R 33/56 (2006.01);
U.S. Cl.
CPC ...
A61K 49/106 (2013.01); A61K 47/48 (2013.01); A61K 49/0002 (2013.01); A61K 49/0021 (2013.01); A61K 49/0026 (2013.01); A61K 49/0052 (2013.01); A61K 49/085 (2013.01); A61K 49/10 (2013.01); A61M 5/007 (2013.01); C07D 401/06 (2013.01); G01R 33/5601 (2013.01);
Abstract

The present invention is in the field of pharmaceuticals and chemical industries. In particular, one aspect of the present invention relates to methods for labeling, imaging and detecting the beta-amyloid (Aβ) peptides, oligomers, and fibrils in vitro and in vivo via magnetic resonance and florescence imaging by using modified carbazole-based fluorophores. A further aspect of the present invention relates to a method of reducing and preventing aggregation of beta-amyloid peptides for Alzheimer's disease (AD) as well as of treating and/or preventing Alzheimer's disease by using the modified carbazole-based fluorophore. The modified carbazole-based fluorophore according to an embodiment of the present invention is prepared by conjugating a carbazole-based fluorophore with magnetic nanoparticles to form a conjugate which is permeable to blood brain barrier of a subject being introduced therewith.


Find Patent Forward Citations

Loading…